Search

everythinglearnresearchcommunity

for

Search:↓

PCOS women with COVID-19 have higher cardiometabolic risks.

Hormones control reproduction and are crucial for body balance.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Decanoic acid may help treat PCOS by reducing androgen levels and improving glucose sensitivity.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

Exposure to plastics may increase the risk of irregular menstrual cycles and symptoms of hormone imbalance in teenage girls.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Finasteride reduces movement issues in Parkinson's disease rats.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Aging causes sweat glands to shrink, leading to skin issues, and blue light can help hair grow.

BMPs are crucial for hair growth and their decrease by androgens leads to hair loss.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Jumonji genes are important for development and their mutations can cause abnormalities, especially in the heart and brain.

Estrogen therapy can reduce skin aging but has cancer risks.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.